These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7530983)

  • 21. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
    Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods.
    Lambrechts AC; van 't Veer LJ; Rodenhuis S
    Ann Oncol; 1998 Dec; 9(12):1269-76. PubMed ID: 9932154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
    Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
    Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.
    Krismann M; Todt B; Schröder J; Gareis D; Müller KM; Seeber S; Schütte J
    J Clin Oncol; 1995 Nov; 13(11):2769-75. PubMed ID: 7595737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of micrometastases by the amplification of tissue-specific genes.
    Neumaier M; Gerhard M; Wagener C
    Gene; 1995 Jun; 159(1):43-7. PubMed ID: 7541767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.
    Hoffmann K; Kerner C; Wilfert W; Mueller M; Thiery J; Hauss J; Witzigmann H
    World J Gastroenterol; 2007 Jan; 13(2):257-63. PubMed ID: 17226905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.
    Lasa A; Garcia A; Alonso C; Millet P; Cornet M; Ramón y Cajal T; Baiget M; Barnadas A
    PLoS One; 2013; 8(9):e74079. PubMed ID: 24058517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CK20 gene expression: technical limits for the detection of circulating tumor cells.
    Champelovier P; Mongelard F; Seigneurin D
    Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.
    Novaes M; Bendit I; Garicochea B; del Giglio A
    Mol Pathol; 1997 Aug; 50(4):209-11. PubMed ID: 9350305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.
    Felton T; Harris GC; Pinder SE; Snead DR; Carter GI; Bell JA; Haines A; Kollias J; Robertson JF; Elston CW; Ellis IO
    Breast; 2004 Feb; 13(1):35-41. PubMed ID: 14759714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
    Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
    Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood.
    Aerts J; Wynendaele W; Paridaens R; Christiaens MR; van den Bogaert W; van Oosterom AT; Vandekerckhove F
    Ann Oncol; 2001 Jan; 12(1):39-46. PubMed ID: 11249047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
    Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
    Luppi M; Morselli M; Bandieri E; Federico M; Marasca R; Barozzi P; Ferrari MG; Savarino M; Frassoldati A; Torelli G
    Ann Oncol; 1996 Aug; 7(6):619-24. PubMed ID: 8879377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
    Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
    Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
    Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
    Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.